CORONAVIRUS SARS-COV-2 MODIFIES ANTITUMOR REDOX STATUS OF BLOOD AND INTERCELLULAR MATRIX IN METASTATIC COLORECTAL CANCER PATIENTS (A PILOT STUDY)
DOI:
https://doi.org/10.15407/exp-oncology.2023.04.483Keywords:
SARS-CoV-2, redox state, metastatic colorectal cancerAbstract
Background. The current studies demonstrate that SARS-CoV-2 infection results in increasing complications incidence and the total risk of death in cancer patients. SARS-CoV-2 infection triggers oxidative stress representing one of the major factors of the inflammation contributing to the complicated course of the diseases including cancer. Aim. To assess the effect of hypoxia caused by SARS-CoV-2 infection on the redox status of blood in patients with metastatic colorectal cancer (mCRC). Materials and Methods. 10 patients with SARS-CoV-2, 11 mCRC patients with metachronous liver disease, and 14 mCRC patients with preceding SARS-CoV-2 infection were included in the study. The data on blood biochemistry (C-reactive protein, ferritin, transferrin, and free iron) were analyzed. The levels of superoxide radicals (ROS) in blood cells were determined by electron paramagnetic resonance (EPR) using the spin trap technique. The metalloproteinase activity was measured by polyacrylamide gel zymography with the addition of gelatin as a substrate. Results. In mCRC patients with prior SARS-CoV-2 infection, a 1.26-fold increase in ROS-generating activity of blood neutrophils was observed compared to mCRC patients with no history of SARS-CoV-2 infection. The blood content of C-reactive protein, transferrin, and free iron in mCRC patients with prior SARS-CoV-2 infection increased by 2, 6, and 1.4 times, respectively. The total activity of gelatinases in platelets and neutrophils in the blood of mCRC patients with prior SARS-CoV-2 infection was 1.4 and 1.2 times higher compared to mCRC patients with no history of SARS-CoV-2 infection. Conclusion. mCRC patients with prior COVID-19 have a higher risk of exacerbation of inflammatory reactions. SARS-CoV-2 infection results in redox dіsbalance, which may contribute to the unfavorable course of the disease.
References
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. https://doi.org/10.1016/S0140-6736(20)30183-5
Dai M, Liu D, Liu M, et al. Patients with cancer appear more vulnerable to SARS-CoV-2: A multicenter study during the COVID-19 outbreak. Cancer Discov. 2020;10(6):783-791. https://doi.org/10.1158/2159-8290.CD-20-0422
Burlaka AP, Ganusevich II, Burlaka AA., et al. Tumor–associated redox state in metastatic colorectal cancer. Exp Oncol. 2019;41(2):148-152. https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-2.13128
Burlaka AP, Ganusevich II, Vovk AV, et al. Redox state of adipose tissue for patients with gastric cancer and its connection with the body mass index and distance from the tumor. Obes Res Clin Pract. 2020;14(1):34-38. https://doi.org/10.1016/j.orcp.2019.10.003
Burlaka AP, Vovk AV, Burlaka AA, et al. Rectal cancer: redox state of venous blood and tissues of blood vessels from electron paramagnetic resonance and its correlation with the five-year survival. Biomed Res Int. 2018;2018:4848652. https://doi.org/10.1155/2018/4848652
DeClerk YA, Perez N, Shimada H, et al. Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res. 1992;52:701-708
Akgun E, Tuzuner MB, Sahin B, et al. Proteins associated with neutrophil degranulation are upregulated in nasopharyngeal swabs from SARS-CoV-2 patients. PLoS One. 2020;15(10):e0240012. https://doi.org/10.1371/journal.pone.0240012
Veras FP, Pontelli MC, Silva CM, et al. SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology. J Exp Med. 2020;217(12):e20201129. https://doi.org/10.1084/jem.20201129
Aschenbrenner AC, Mouktaroudi M, Krämer B, et al. Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients. Genome Med. 2021;13(1):7. https://doi.org/10.1186/s13073-020- 00823-5
Fu J, Kong J, Wang W, et al. The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China. Thrombos Res. 2020;192:3–8. https://doi.org/10.1016/j. thromres.2020.05.006
Webb BJ, Peltan ID, Jensen P, et al. Clinical criteria for COVID-19-associated hyper inflammatory syndrome: a cohort study. Lancet Rheumatol. 2020;2(12):e754-e763. https://doi.org/10.1016/S2665-9913(20)30343-X
Xu P, Zhou Q, Xu J. Mechanism of thrombocytopenia in COVID-19 patients. Ann Hematol. 2020;99(6):1205-1208. https://doi.org/10.1007/s00277-020-04019-0
Lichtenberger LM, Vijayan KV. Is COVID-19-induced platelet activation a cause of concern for patients with cancer? Cancer Res. 2021;81(5):1209-1211. https://doi.org/10.1158/0008-5472.CAN-20-3691
Obi AT, Barnes GD, Napolitano LM, et al. Venous thrombosis epidemiology, pathophysiology, and anticoagulant therapies and trials in severe acute respiratory syndrome coronavirus 2 infection. J Vasc Surg Venous Lymphat Disord. 2021;9(1):23-35. https://doi.org/10.1016/j.jvsv.2020.08.030
Schlesinger M. Role of platelets and platelet receptors in cancer metastasis. J Hematol Oncol. 2018;11(1):125. doi: 10.1186/s13045-018-0669-2
Zhang B, Yu Y, Hubert SM, et al. Prognostic value of pro-inflammatory neutrophils and c-reactive protein in cancer patients with coronavirus disease 2019: A multi-center, retrospective study. Front Pharmacol. 2020;11:576994. https://doi.org/10.3389/fphar.2020.576994
Sanchez-Pina JM, Rodríguez Rodriguez M, Castro Quismondo N, et al. Clinical course and risk factors for mortality from COVID-19 in patients with haematological malignancies. Eur J Haematol. 2020;105(5):597-607. https://doi.org/10.1111/ejh.13493
Banchini F, Cattaneo M, Capelli P, et al. Serum ferritin levels in inflammation: a retrospective comparative analysis between COVID-19 and emergency surgical non-COVID-19 patients. World J Emerg Surg. 2021;16(1):9. https://doi.org/10.1186/s13017-021-00354-3
Birndt S, Schenk T, Heinevetter B, et al. Hemophagocytic lymphohistiocytosis in adults: collaborative analysis of 137 cases of a nationwide German registry. J Cancer Res Clin Oncol. 2020;146(4):1065-1077. https://doi.org/10.1007/s00432-020-03139-4
Ruscitti P, Cipriani P, Ciccia F, et al. H-ferritin and CD68(+)/H-ferritin(+) monocytes/macrophages are increased in the skin of adult-onset Still’s disease patients and correlate with the multi-visceral involvement of the disease. Clin Exp Immunol. 2016;186(1):30-38. https://doi.org/10.1111/cei.12826
Lachmann G, Knaak C, Vorderwülbecke G, et al. Hyperferritinemia in critically ill patients. Crit Care Med. 2020;48(4):459-465. https://doi.org/10.1097/CCM.0000000000004131
ten Kate J, Drenth JP, Kahn MF, et al. Iron saturation of serum ferritin in patients with adult onset Still's disease. J Rheumatol. 2001;28(10):2213–2215.
Ware LB, Matthay MA. The acute respiratory distress syndrome. New Engl J Med. 2000. 342(18):1334-1349. https://doi.org/10.1056/NEJM200005043421806
Khiroya H, Turner AM. The role of iron in pulmonary pathology. Multidisciplin Respir Med. 2015;10:34 https:// doi.org/10.1186/s40248-015-0031-2
Lipinski B, Pretorius E. Iron-induced fibrin in cardiovascular disease. Curr Neurovascul Res. 2013;10(3):269-274. https://doi.org/10.2174/15672026113109990016
Giannis D, Ziogas IA, Gianni P. Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past. J Clin Virol. 2020;127:104362 https://doi.org/10.1016/j.jcv.2020.104362
George PM, Wells AU, Jenkins RG. Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy. Lancet Respir Med. 2020;8(8):807-815. https://doi.org/10.1016/S2213-2600(20)30225-3
McLaughlin K-M, Bechtel M, Bojkova D, et al. COVID-19-related coagulopathy — is transferrin a missing link?
Diagnostics. 2020;10(8):539. https://doi.org/10.3390/diagnostics10080539
Tang X, Zhang Z, Fang M, et al. Transferrin plays a central role in coagulation balance by interacting with clotting factors. Cell Res. 2020;30(2):119-132. https://doi.org/10.1038/s41422-019-0260-6
Palacios-Acedo AL, Mège D, Crescence L, et al. Platelets, thrombo-inflammation, and cancer: collaborating with the enemy. Front Immunol. 2019;10:1805. https://doi.org/10.3389/fimmu.2019.01805
Gonzalez-Avila G, Sommer B, Mendoza-Posada DA, et al. Matrix metalloproteinases participation in the meta- static process and their diagnostic and therapeutic applications in cancer. Crit Rev Oncol Hematol. 2019;137:57- 83. https://doi.org/10.1016/j.critrevonc.2019.02.010
Ozkan E, Bakar-Ates F. The trinity of matrix metalloproteinases, inflammation, and cancer: a literature review of recent updates. Antiinflamm Antiallergy Agents Med Chem. 2020;19(3):206-221. https://doi.org/10.2174/1871523018666191023141807
Gobin E, Bagwell K, Wagner J. et al. A pan-cancer perspective of matrix metalloproteases (MMP) gene expression profile and their diagnostic/prognostic potential. BMC Cancer. 2019;19:581. https://doi.org/10.1186/s12885-019-5768-0
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Experimental Oncology
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
